Focus: Infection Control

Chinese city plans to build coronavirus hospital in days

Wuhan is constructing a 1,000-bed facility with prefab buildings


The Chinese city of Wuhan is working to build a 1,000-bed hospital in just 10 days to treat victims of the epidemic, according to an article on the Guardian website.

The hospital is being built with prefabricated buildings around a vacation complex on the outskirts of the city.

China has a history of constructing hospitals at short notice in response to major health crises. 

In 2003, during the SARAS outbreak 7,000 workers in Beijing built the Xiaotangshan hospital in the northern suburbs in a week.

Read the article.

 



January 30, 2020


Topic Area: Infection Control


Recent Posts

Reframing the Construction Manager as a Community Manager

Managers must work with patients, community residents and other interested parties to ensure a smooth, successful construction projects


Health First Celebrates 'Topping Off' Ceremony for New Cape Canaveral Hospital Campus

Construction is slated to finish by the end of 2026 or early 2027.


The University of Hawai'i Cancer Center Caught Up in Cyberattack

Investigations are still ongoing to assess other sensitive information that may have been impacted.


Mature Dry Surface Biofilm Presents a Problem for Candida Auris

Multiple methods are described in the literature, but no consensus has been reached for disinfection efficacy tests against biofilms.


Sutter Health's Arden Care Center Officially Opens

With an adaptive reuse of an underutilized office building, the 70,000 square-foot facility was renovated to meet current healthcare standards.


 
 


FREE Newsletter Signup Form

News & Updates | Webcast Alerts
Building Technologies | & More!

 
 
 


All fields are required. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

 
 
 
 

Healthcare Facilities Today membership includes free email newsletters from our facility-industry brands.

Facebook   Twitter   LinkedIn   Posts

Copyright © 2023 TradePress. All rights reserved.